Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) Leverage/Terbalik
$14,28
▼ -0,54 (-3,64%)
Perubahan 1 hari
$13,80 – $24,15
Rentang 52 minggu
Bobot 10 kepemilikan teratas67,48%
Jumlah posisi efektif10,0
Posisi di atas 1%53
Aset bersih
$20.7M
Kepemilikan
73
Per tanggal
31 Juli 2026
PILL Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 6 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -31,97% | ▼ -31,96% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Maks | ▼ -36,36% | ▼ -36,36% |
Volatilitas 1T·
Volatilitas 3Y·
Penurunan Maksimum 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Bulan lalu (Jul 2026)
+$8K
Kuartal berakhir Jul 2026
+$914K
12 bulan terakhir
-$3.9M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 73 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| GOLDMAN FINANCIAL | · | $4.6M | 22,36 | 4.616.827 | STIV | US |
| Sekuritas tidak diketahui | · | $3.4M | 16,36 | 1 | DO | US |
| DREYFUS | · | $1.7M | 8,14 | 1.680.337 | STIV | US |
| Sekuritas tidak diketahui | · | $1.5M | 7,41 | 1 | DO | US |
| CRINETICS PHARMACEUTICALS IN | 22663K107 | $572K | 2,77 | 6.844 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $500K | 2,42 | 7.580 | EC | US |
| ATAIBECKLEY INC | 04650F101 | $446K | 2,16 | 62.140 | EC | US |
| Definium Therapeutics, Inc | 24477V105 | $440K | 2,13 | 10.109 | EC | CA |
| GOLDMAN SACHS LIQ ES FD A | · | $420K | 2,03 | 420.000 | STIV | US |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $354K | 1,72 | 17.451 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $348K | 1,68 | 6.348 | EC | US |
| CORCEPT THERAPEUTICS INC | 218352102 | $344K | 1,67 | 3.007 | EC | US |
| ALUMIS INC | 022307102 | $331K | 1,60 | 11.709 | EC | US |
| NUVATION BIO INC | 67080N101 | $325K | 1,57 | 51.286 | EC | US |
| TREVI THERAPEUTICS INC | 89532M101 | $320K | 1,55 | 17.529 | EC | US |
| LIQUIDIA CORP | 53635D202 | $303K | 1,47 | 3.600 | EC | US |
| NEKTAR THERAPEUTICS | 640268306 | $292K | 1,42 | 4.138 | EC | US |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | $281K | 1,36 | 15.331 | EC | US |
| BRISTOL-MYERS SQUIBB CO | 110122108 | $276K | 1,34 | 4.226 | EC | US |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $274K | 1,33 | 7.137 | EC | US |
| OMEROS CORP | 682143102 | $273K | 1,32 | 23.028 | EC | US |
| LIGAND PHARMACEUTICALS | 53220K504 | $272K | 1,32 | 947 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $271K | 1,31 | 10.270 | EC | US |
| VERADERMICS INC | 922967104 | $265K | 1,28 | 2.526 | EC | US |
| PACIRA PHARMACEUTICALS INC | 695127100 | $265K | 1,28 | 10.029 | EC | US |
| VIATRIS INC | 92556V106 | $262K | 1,27 | 14.896 | EC | US |
| JAZZ PHARMACEUTICALS PLC | G50871105 | $259K | 1,25 | 1.023 | EC | US |
| ETON PHARMACEUTICALS INC | 29772L108 | $258K | 1,25 | 5.548 | EC | US |
| MAZE THERAPEUTICS INC | 578784100 | $257K | 1,25 | 9.551 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $257K | 1,24 | 1.972 | EC | US |
| CSM -N.R CERT | 415858109 | $254K | 1,23 | 6.543 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $253K | 1,22 | 985 | EC | US |
| ROYALTY PHARMA PLC- CL A | G7709Q104 | $252K | 1,22 | 4.308 | EC | US |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | $247K | 1,19 | 6.167 | EC | US |
| PRESTIGE BRANDS HOLDINGS INC | 74112D101 | $240K | 1,16 | 4.781 | EC | US |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | $239K | 1,16 | 6.750 | EC | US |
| ORGANON & CO | 68622V106 | $238K | 1,15 | 17.557 | EC | US |
| ELI LILLY & COMPANY | 532457108 | $237K | 1,15 | 206 | EC | US |
| EYEPOINT INC | 30233G209 | $233K | 1,13 | 19.051 | EC | US |
| HARMONY BIOSCIENCES HOLDINGS | 413197104 | $233K | 1,13 | 6.619 | EC | US |
| SUPERNUS PHARMACEUTICALS INC | 868459108 | $232K | 1,13 | 5.209 | EC | US |
| PFIZER INC | 717081103 | $229K | 1,11 | 9.176 | EC | US |
| WAVE LIFE SCIENCES LTD | Y95308105 | $229K | 1,11 | 41.500 | EC | US |
| PHIBRO ANIMAL HEALTH CORP-A | 71742Q106 | $229K | 1,11 | 6.294 | EC | US |
| ANI PHARMACEUTICALS INC | 00182C103 | $227K | 1,10 | 2.870 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $226K | 1,10 | 3.832 | EC | US |
| ZOETIS INC | 98978V103 | $223K | 1,08 | 2.889 | EC | US |
| OCULAR THERAPEUTIX INC | 67576A100 | $220K | 1,06 | 26.875 | EC | US |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | $219K | 1,06 | 27.065 | EC | US |
| RAPPORT THERAPEUTICS INC | 75383L102 | $218K | 1,05 | 5.313 | EC | US |
Rincian sektor
Dividen 26 pembayaran
0,41%Imbal hasil TTM
$0,06Pembayaran TTM / saham
Kuartalan
(est.)
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 22 Sep. 2026 | $0,0010 |
| 23 Juni 2026 | $0,0150 |
| 24 Maret 2026 | $0,0100 |
| 23 Des. 2025 | $0,0330 |
| 23 Sep. 2025 | $0,0100 |
| 24 Juni 2025 | $0,0240 |
| 25 Maret 2025 | $0,0180 |
| 23 Des. 2024 | $0,0130 |
| 24 Sep. 2024 | $0,0290 |
| 25 Juni 2024 | $0,0220 |
| 19 Maret 2024 | $0,0270 |
| 21 Des. 2023 | $0,0380 |
| 19 Sep. 2023 | $0,0350 |
| 21 Juni 2023 | $0,0490 |
| 21 Maret 2023 | $0,0190 |
| 20 Des. 2022 | $0,0320 |
| 20 Sep. 2022 | $0,0170 |
| 22 Juni 2022 | $0,0040 |
| 22 Maret 2022 | $0,0080 |
| 24 Sep. 2019 | $0,0150 |
| 25 Juni 2019 | $0,0220 |
| 19 Maret 2019 | $0,0570 |
| 27 Des. 2018 | $0,0990 |
| 25 Sep. 2018 | $0,0430 |
| 19 Juni 2018 | $0,0520 |
| 19 Des. 2017 | $0,0140 |
Pemilik institusional (13F) 7 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.348.938 | 69,77% | 74.692 | Saham | 30 Juni 2026 |
| GTS SECURITIES LLC | $458.543 | 23,72% | 25.390 | Saham | 30 Juni 2026 |
| Tower Research Capital LLC (TRC) | $105.163 | 5,44% | 5.823 | Saham | 30 Juni 2026 |
| UBS Group AG | $18.385 | 0,95% | 1.018 | Saham | 30 Juni 2026 |
| FINANCIAL CONSULATE, INC | $1.806 | 0,09% | 100 | Saham | 30 Juni 2026 |
| SIMPLEX TRADING, LLC | $397 | 0,02% | 22 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $38 | 0,00% | 2 | Saham | 30 Juni 2026 |